Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $23,849 - $51,946
1,591 Added 1.99%
81,563 $1.22 Million
Q2 2023

Aug 14, 2023

BUY
$29.76 - $46.14 $654,898 - $1.02 Million
22,006 Added 37.96%
79,972 $2.6 Million
Q1 2023

May 15, 2023

SELL
$38.09 - $57.79 $2.44 Million - $3.71 Million
-64,115 Reduced 52.52%
57,966 $2.27 Million
Q4 2022

Feb 21, 2023

BUY
$40.54 - $56.2 $2.07 Million - $2.87 Million
51,089 Added 71.96%
122,081 $6.45 Million
Q3 2022

Nov 14, 2022

SELL
$36.98 - $49.2 $1.05 Million - $1.4 Million
-28,510 Reduced 28.65%
70,992 $3.22 Million
Q2 2022

Aug 15, 2022

SELL
$28.03 - $45.8 $8,268 - $13,511
-295 Reduced 0.3%
99,502 $3.62 Million
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $307,195 - $462,894
10,506 Added 11.77%
99,797 $4.12 Million
Q4 2021

Feb 11, 2022

BUY
$39.32 - $61.61 $651,021 - $1.02 Million
16,557 Added 22.76%
89,291 $3.81 Million
Q3 2021

Nov 12, 2021

SELL
$44.0 - $65.8 $66,000 - $98,700
-1,500 Reduced 2.02%
72,734 $4 Million
Q2 2021

Aug 13, 2021

BUY
$44.66 - $63.06 $559,634 - $790,204
12,531 Added 20.31%
74,234 $3.55 Million
Q1 2021

May 14, 2021

BUY
$46.31 - $62.7 $818,436 - $1.11 Million
17,673 Added 40.14%
61,703 $3.13 Million
Q4 2020

Feb 16, 2021

BUY
$55.51 - $69.94 $192,231 - $242,202
3,463 Added 8.54%
44,030 $2.77 Million
Q3 2020

Nov 13, 2020

SELL
$42.19 - $69.61 $2.3 Million - $3.79 Million
-54,414 Reduced 57.29%
40,567 $2.73 Million
Q2 2020

Aug 11, 2020

BUY
$27.55 - $43.28 $976,867 - $1.53 Million
35,458 Added 59.57%
94,981 $3.98 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $310,552 - $640,950
13,409 Added 29.08%
59,523 $1.87 Million
Q4 2019

Feb 14, 2020

BUY
$27.97 - $40.38 $1.29 Million - $1.86 Million
46,114 New
46,114 $1.86 Million

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.